Follow-up delta CHA2DS2-VASc score better predicts CVA in A-fib

January 9, 2018

(HealthDay)—Assessing change in the CHA2DS2-VASc score over time is more predictive of ischemic stroke in patients with atrial fibrillation (AF) than the baseline score, according to a study published in the Jan. 16 issue of the Journal of the American College of Cardiology.

Tze-Fan Chao, M.D., from the Taipei Veterans General Hospital in Taiwan, and colleagues compared the effectiveness of assessing ischemic stroke risk in 31,039 patients with AF using the CHA2DS2-VASc , based on the baseline risk factors, and the Delta CHA2DS2-VASc score, which reflects the change in score between baseline and follow-up.

The researchers found that the CHA2DS2-VASc score remained unchanged in only 40.8 percent of patients. The majority of the 4,103 patients who experienced ischemic stroke had a Delta CHA2DS2-VASc score ≥1 (89.4 percent, versus 54.6 percent in patients without ischemic stroke). Nearly two-thirds of who had an ischemic stroke (64.4 percent) had at least one new-onset comorbidity, most commonly hypertension. The Delta CHA2DS2-VASc score significantly better predicted ischemic stroke compared to baseline or follow-up CHA2DS2-VASc scores, based on the C-index and the net reclassification index.

"The Delta CHA2DS2-VASc score, reflecting the change in score between baseline and follow-up, was strongly predictive of , reflecting how stroke risk in AF is a dynamic process due to increasing age and incident comorbidities," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Explore further: Combining risk score tools improves stroke prediction for atrial fibrillation patients

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Combining risk score tools improves stroke prediction for atrial fibrillation patients

March 19, 2017
Combining two independent, scientifically-proven risk measurements allows physicians to better predict an atrial fibrillation patient's risk of stroke or death. The tools also help determine the need for blood thinners in ...

Routine oral anticoagulants may not benefit all with A-fib

January 21, 2015
(HealthDay)—Benefit from routine anticoagulation therapy to reduce risk of ischemic stroke may be unlikely in patients with atrial fibrillation (AF) and a CHA2DS2-VASc score of 1, according to a study published in the Jan. ...

Combining risk scores improves decision-making process for AFib patients and physicians

May 11, 2017
Physicians and atrial fibrillation patients must weigh the risks and benefits of using blood thinners to prevent stroke, bleeding, and death—but current guidelines don't do enough to discern a patient's true risk, researchers ...

CHADS2 risk score assigns over one-third of stroke patients to low or intermediate stroke risk

September 1, 2013
The CHADS2 stroke risk scores 0 or 1 assign more than one-third of patients in atrial fibrillation with stroke to low or intermediate risk not mandating oral anticoagulation, according to research presented at ESC Congress ...

GPs undertreat women with AF

September 1, 2013
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that ...

New study finds antithrombotic therapy has no benefit for low-risk atrial fibrillation patients

March 17, 2017
Findings from a large, community-based study show that antithrombotic therapy doesn't decrease low-risk atrial fibrillation patients' risk of suffering a stroke within five years. In fact, researchers found that low-risk ...

Recommended for you

Drug now in clinical trials for Parkinson's strengthens heart contractions in animals

July 20, 2018
A drug currently in clinical trials for treating symptoms of Parkinson's disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers.

'Good cholesterol' may not always be good

July 19, 2018
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) - also known as 'good cholesterol' - according to a study led by researchers in the University of Pittsburgh Graduate ...

Using adrenaline in cardiac arrests results in less than 1 percent more people leaving hospital alive

July 18, 2018
A clinical trial of the use of adrenaline in cardiac arrests has found that its use results in less than 1% more people leaving hospital alive—but almost doubles the risk of severe brain damage for survivors of cardiac ...

Omega 3 supplements have little or no heart or vascular health benefit: review

July 17, 2018
New evidence published today shows there is little or no effect of omega 3 supplements on our risk of experiencing heart disease, stroke or death.

Researchers discover new genes associated with heart function

July 17, 2018
A new study from an international research team, led by Dr. Yalda Jamshidi at St George's, University of London, has identified new genes associated with heart function and development.

Southern diet could be deadly for people with heart disease

July 12, 2018
People with a history of heart disease who eat a traditional Southern diet are more likely to die than those who follow a Mediterranean dietary pattern, according to new research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.